N-EthylGlucamine CAS:14216-22-9

N-Ethylglucamine, also referred to as NEGA, serves a wide range of applications across different industries. In the pharmaceutical sector, it is utilized as a pharmaceutical excipient and buffering agent in drug formulations. Its biocompatibility and low toxicity make it ideal for use in parenteral formulations and medical applications. Moreover, N-Ethylglucamine finds application in biotechnology for protein purification, enzyme stabilization, and cell culture media preparation. Its ability to stabilize proteins and maintain cell viability enhances the efficiency of bioprocessing techniques and supports various biopharmaceutical production processes. Furthermore, this compound is used in the synthesis of contrast agents for medical imaging procedures such as MRI (magnetic resonance imaging) and PET (positron emission tomography). Its chelating properties and low osmolality make it suitable for enhancing imaging quality and patient safety during diagnostic examinations. Additionally, N-Ethylglucamine is employed in chemical research for studying carbohydrate chemistry, developing new reactions, and designing bioactive compounds. Its role in organic synthesis and medicinal chemistry contributes to advancements in drug discovery, material science, and biochemical engineering. In summary, N-Ethylglucamine plays a vital role in pharmaceutical formulations, biotechnological processes, medical imaging, and chemical research. Its diverse applications underscore its significance in enhancing healthcare technologies, supporting scientific innovation, and improving the quality of life for individuals worldwide.